Dr. Kenneth T. Shimizu, MD

Dr. Shimizu practices at Scripps Green Hospital in La Jolla, California, part of Scripps Health.

Dr. Shimizu's NPI, 1326032129, was assigned on September 7, 2005. Dr. Shimizu graduated from David Geffen School of Medicine at UCLA in 1988. Dr. Shimizu's California license number on file is G67647.

Dr. Shimizu's primary practice is Scripps Green Hospital, at 10666 North Torrey Pines Road, La Jolla, CA 92037 in San Diego County. The practice phone is (858) 554-3600.

Dr. Shimizu's primary practice is Scripps Green Hospital in La Jolla, California, part of Scripps Health. Dr. Shimizu is also affiliated with Scripps Memorial Hospital La Jolla. The medical group on file is Scripps Clinic Medical Group. Dmand AI also links Dr. Shimizu to 1 more hospital, 2 medical groups, 1 breast imaging center, 1 group practice or clinic and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shimizu practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Shimizu's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Shimizu is board certified in radiation oncology by the American Board of Radiology. Dr. Shimizu has a license on file in California.

Dmand AI lists brain cancer radiation, brain tumor radiation, breast cancer radiation, colorectal cancer radiation, head & neck cancer radiation, lung cancer radiation and prostate cancer radiation among the conditions Dr. Shimizu treats.

CMS data shows 2,113 Medicare services from Dr. Shimizu across 24 procedure codes in 2024, for 367 Medicare patients. Medicare paid $164,675 for them. Every service was in an office.

CMS counts 367 Medicare patients who saw Dr. Shimizu in 2024. The largest group is 65 to 74, with 177 patients. 75% of them have cancer, and 72% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Shimizu's median patient age at 66, with 81% women.

In 2024, Dr. Shimizu wrote 70 Medicare Part D claims for 33 patients. 83% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $94 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

Dr. Shimizu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shimizu as offering telehealth.

Dmand AI links 2 papers to Dr. Shimizu, published from 2013 to 2021. Dr. Shimizu's most frequent co-authors are Sharona Ben-Haim, MD, Christopher M. Duma, MD and David W. Hodgens, MD.

CMS Open Payments shows 40 general payments to Dr. Shimizu from 19 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $138.

Dr. Shimizu graduated from David Geffen School of Medicine at UCLA in 1988.

Dr. Shimizu is in network with 6 carriers, including Elevance, Blue Cross Blue Shield of Massachusetts and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.